2023 Funded Grants
-
Blockade of Human CD21 with a Humanized Blocking Antibody
Michael Carroll, Ph.D.
Boston Children's Hospital
-
Uncovering the Molecular Signatures of Treatment Response in LN
Shaun Jackson, M.D., Ph.D.
Seattle Children's Hospital
-
Targeting NETs in Obstetric APS
Jason Knight, M.D., Ph.D.
The Regents of the University of Michigan
-
S100A4 in Lupus Nephritis
Chandra Mohan, M.D., Ph.D.
University of Houston
-
Dissecting the Transition from Autoreactivity to Disease in Lupus Nephritis
Boris Reizis, Ph.D.
New York University Grossman School of Medicine
-
Precision Targeting of Lupus IGHV4-34+ Pathogenic B Cells with CAR T Cells
Marco Ruella, M.D.
The Trustees of the University of Pennsylvania
-
PARP7 as a New Negative Feedback Regulator of Type I Interferon Signaling
Nan Yan, Ph.D.
The University of Texas Southwestern Medical Center
2022 Funded Grants
-
SGLT2 inhibition as a novel treatment for lupus nephritis
Jennifer Anolik, MD, PhD
University of Rochester
-
Targeting Hippo signaling to downregulate IFN production in SLE
J. Michelle Kahlenberg, MD, PhD
University of Michigan
-
Targeting CXCR6+ T cell recruitment and memory in cutaneous lupus
Jillian Richmond, PhD
Tufts University Cummings School of Veterinary Medicine